COGT Operating Expenses

Cogent Biosciences Inc · Operating Expenses

COGT logo

COGT Operating Expenses

Latest reported$102.64M
COGT Quarterly Operating Expenses ($4.76M → $102.64M)
High-resolution chart · PNG

COGT operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cogent Biosciences Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
102,638,000
102,452,000
98,316,000
83,355,000
74,425,000
74,933,000
73,734,000
75,414,000
64,387,000
62,404,000
58,228,000
59,580,000
47,085,000
43,237,000
43,745,000
36,821,000
35,855,000
31,418,000
25,640,000
19,819,000
17,292,000
12,800,000
11,456,000
52,508,000
2,802,000
3,674,000
2,694,000
13,056,000
13,679,000
14,894,000
12,809,000
12,619,000
11,105,000
9,206,000
9,003,000
9,501,000
8,112,000
7,896,000
24,875,000
4,759,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.